Know Cancer

or
forgot password

A Pilot Study of Pentoxifylline-Therapy for Acute Alcoholic Hepatitis


Phase 3
18 Years
N/A
Not Enrolling
Both
Hepatitis, Alcoholic

Thank you

Trial Information

A Pilot Study of Pentoxifylline-Therapy for Acute Alcoholic Hepatitis


Inclusion Criteria:



- Inpatient with acute alcoholic hepatitis

- Model for End-Stage Liver Disease (MELD) of 15 or greater

- Recent alcohol abuse

Exclusion Criteria:

- Recent infection

- Other life threatening disease

- Severe coagulopathy

- Another non-alcoholic cause of liver disease

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Outcome Measure:

Survival at 90 days

Principal Investigator

Michael R Lucey, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Wisconsin, Madison

Authority:

United States: Institutional Review Board

Study ID:

M-2004-0388

NCT ID:

NCT00205049

Start Date:

March 2005

Completion Date:

July 2008

Related Keywords:

  • Hepatitis, Alcoholic
  • acute alcoholic hepatitis
  • Hepatitis, Alcoholic
  • Hepatitis
  • Hepatitis A

Name

Location

University of WisconsinMadison,, Wisconsin  53792-5666